跳至主要内容
临床试验/IRCT138808111414N4
IRCT138808111414N4已完成1 期

Efficacy assessment of the Superporous Hydrogel (SPH) polymer-based oral insulin delivery systems on plasma glucose in patients with type 1 diabetes

Endocrinology and Metabolism Research Center0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 45 years(—)
性别
All

入选标准

  • inclusion criteria: type1 diabetes, age of 17 - 45 years and the BMI levels =19 and = 27 kg/m2.
  • Exclusion criteria : any significant GI symptoms, previous hypersensitivity to polymer, clinically diagnosed diabetic gastroparesia, C-peptide> 0.5 ng/dl, forcing patients to use drugs intervention with insulin during study (LHRH agonists, cimetidine, ranitidine, quinolones, estrogen, diuretics, glucocorticoids, ß blockers, somatostatins, pegvisomant, thiazolidinediones and herbal medicines), history of GI bleeding, history of uncontrolled thyroid disease, history of acute febrile illness, history of blood donate in the past 3 months, psychological disease, cardiac disease.

排除标准

  • 未提供

研究者

发起方
Endocrinology and Metabolism Research Center

相似试验